**Inpatient Discharge Summary**  **Patient Information:**   Emily Thompson, MRN#: 568421355, is a 54 y.o. female, admitted to the Medical Oncology service due to worsening symptoms of chronic lymphocytic leukemia (CLL).   Admission Date: 07/21/2023   Discharge Date: 08/15/2023   Attending Provider: Dr. Alexander Reid   Treatment Team: Dr. Sarah Howell, Medical Oncology Fellow   Hospital Problems Noted - Resolved   POA Active Problems   Chronic lymphocytic leukemia 01/15/2018 - Present Yes   Severe fatigue and malaise 08/01/2023 - Present Yes   Hospital Course: Brief Overview   Ms. Emily Thompson was admitted with severe fatigue and a high white blood cell count. Her condition required updated chemotherapy protocols and supportive care for symptom management. Ms. Thompson responded adequately to the new chemotherapy regimen, started on 07/25/2023, with gradual improvement in her fatigue levels.    She experienced neutropenia and was managed with G-CSF and appropriate antibiotic coverage. Ongoing monitoring and supportive care were managed well, with Ms. Thompson making sufficient progress to allow for home-based recovery and outpatient follow-up.  **Plans for Continuation of Care:**   Follow-up is scheduled with City Oncology Center for continued CLL management.   Next Appointment: 08/25/2023 at 10:00 AM with Dr. Alexander Reid, Hematology-Oncology Specialist   Reassessment of therapy effectiveness and potential adjustment of her chemotherapy regimen based on her response and side effects profile.   Ms. Thompson has been counseled on symptoms that would necessitate a sooner revisitation to healthcare services, including fever, uncontrolled pain, or signs of infection.  **Discharge Condition:**   General health status: Stable, with signs of improvement   Mental status: Alert and oriented, coping well with her disease process   Weight: 68 kg (Discharge weight; stable compared to admission weight)   [Pertinent Discharge Physical Exam]   General: No distress, appears well-hydrated and nourished   HEENT: Normocephalic, atraumatic   Cardiovascular: Regular rhythm, no murmurs   Respiratory: Clear to auscultation bilaterally   Abdomen: Soft, non-tender   Extremities: No edema, full range of motion    **Discharge Medications:**   Chlorambucil 2 mg, Oral, ONCE DAILY   Prednisone 10 mg, Oral, ONCE DAILY   Ondansetron 8 mg, Oral, AS NEEDED for nausea     **Home Care Instructions:**   Ms. Thompson will continue with oral chemotherapy as prescribed. She has been instructed on medication adherence, side effects monitoring, and the need to maintain adequate hydration and nutrition.   Educational material provided regarding infection risks and the importance of maintaining personal hygiene.   Phone: 453-291-3502 for emergency contact   [Pertinent Information or Suggestions for Patients]   Ms. Thompson was advised to avoid crowds and individuals with infections due to her compromised immune status. Regular handwashing and use of sanitizers recommended.    It is advised that Ms. Thompson regularly measures her temperature and reports any fevers immediately to her healthcare provider or the emergency room.  **Contact Information for Follow-Up:**   Primary Oncology Care: Dr. Alexander Reid at City Oncology Center   Phone: 321-555-8976   Email for routine communications: info@cityoncologycenter.com    **Discharge Signed by:**   Dr. Sarah Howell, dated 08/15/2023 at 04:30 PM.   **Final Note:** Ms. Emily Thompson was appreciative of the care received and verbalized understanding of her discharge instructions. She feels prepared to manage her care at home with the support of her family and home health services. 